Cargando…
The Role of Transforming Growth Factor-β Signaling in Myxomatous Mitral Valve Degeneration
Mitral valve prolapse (MVP) due to myxomatous degeneration is one of the most important chronic degenerative cardiovascular diseases in people and dogs. It is a common cause of heart failure leading to significant morbidity and mortality in both species. Human MVP is usually classified into primary...
Autores principales: | Tang, Qiyu, McNair, Andrew J., Phadwal, Kanchan, Macrae, Vicky E., Corcoran, Brendan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152029/ https://www.ncbi.nlm.nih.gov/pubmed/35656405 http://dx.doi.org/10.3389/fcvm.2022.872288 |
Ejemplares similares
-
TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease
por: McNair, Andrew J., et al.
Publicado: (2023) -
TGF‐β‐induced PI3K/AKT/mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease
por: Tang, Qiyu, et al.
Publicado: (2023) -
Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration
por: Tan, Karen, et al.
Publicado: (2019) -
Disease Severity-Associated Gene Expression in Canine Myxomatous Mitral Valve Disease Is Dominated by TGFβ Signaling
por: Markby, Greg R., et al.
Publicado: (2020) -
Telotristat ethyl reverses myxomatous changes in mice mitral valves
por: Wang, Xinmei, et al.
Publicado: (2022)